SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

06 Feb 2024 Evaluate
A slight decline in the revenue of Rs. 1667.60 millions was seen for the December 2023 quarter as against Rs. 1689.56 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 321.09  millions from Rs. 375.30 millions ,decline by -14.44%.Operating Profit saw a handsome growth to 613.36 millions from 582.40 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202312 202212 % Var
Sales 1667.60 1689.56 -1.30 1667.60 1689.56 -1.30 1667.60 1689.56 -1.30
Other Income 67.54 64.95 3.99 67.54 64.95 3.99 67.54 64.95 3.99
PBIDT 613.36 582.40 5.32 613.36 582.40 5.32 613.36 582.40 5.32
Interest 0.37 3.54 -89.55 0.37 3.54 -89.55 0.37 3.54 -89.55
PBDT 515.56 578.86 -10.94 515.56 578.86 -10.94 515.56 578.86 -10.94
Depreciation 78.55 66.77 17.64 78.55 66.77 17.64 78.55 66.77 17.64
PBT 437.01 512.09 -14.66 437.01 512.09 -14.66 437.01 512.09 -14.66
TAX 115.92 136.79 -15.26 115.92 136.79 -15.26 115.92 136.79 -15.26
Deferred Tax -10.08 -4.29 134.97 -10.08 -4.29 134.97 -10.08 -4.29 134.97
PAT 321.09 375.30 -14.44 321.09 375.30 -14.44 321.09 375.30 -14.44
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 36.78 34.47 6.70 36.78 34.47 6.70 36.78 34.47 6.70

Blue Jet Healthcare Share Price

413.30 -9.55 (-2.26%)
20-Apr-2026 15:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.30
Dr. Reddys Lab 1234.00
Cipla 1231.50
Zydus Lifesciences 937.50
Lupin 2329.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×